Close Menu

Somalogic

The firm said it will use the funds to support development of new life science tools and clinical diagnostics based on its Somamer affinity agent technology.

While SomaScan is the company's main source of revenue, it continues to develop its Dx business and will launch its first test in the second half of 2016.

Under the agreement, BMS has access to the 1,310 reagents in the public version of SomaLogic's SOMAscan assay along with a number of custom-developed reagents.

Pacific Biosciences announced this week that it has reached the final developmental milestone of its commercialization and licensing agreement with Roche.

Investigators from SomaLogic and elsewhere found proteins whose expression levels vary in Duchenne muscular dystrophy, often in conjunction with patients' age.

NEW YORK (GenomeWeb) – In a notice filed on Friday with the US Securities and Exchange Commission, SomaLogic disclosed that it has raised $16.5 million. According to the SEC document, the sale took place on Oct. 17 with equity going to two unidentified investors.

NEW YORK (GenomeWeb) – With new installations and rapidly growing revenues, Somalogic's SOMAscan platform is becoming a significant player in the protein biomarker discovery service space.

NEW YORK (GenomeWeb) – Somalogic said today that Novartis has extended its multi-year research agreement covering the use of Somalogic's aptamer-based proteomics platform for drug development work.

NEW YORK (GenomeWeb) – Children's Hospital Colorado and SomaLogic today announced a collaboration aimed at the discovery of protein biomarkers for diagnosing and managing childhood diseases.

NEW YORK (GenomeWeb) – SomaLogic and NEC today announced an exclusive deal granting NEC exclusive marketing rights to the Somascan assay in Japan.

Pages

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.